Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
Domain-

CCAR1 PIAS3

4.80e-04212921.10.720.30
DomainSAP

CCAR1 PIAS3

5.27e-0422292PF02037
DomainSAP

CCAR1 PIAS3

5.77e-0423292SM00513
DomainSAP

CCAR1 PIAS3

6.83e-0425292PS50800
DomainSAP_dom

CCAR1 PIAS3

6.83e-0425292IPR003034
DomainPkinase_Tyr

MET BRAF ROR1

1.03e-03129293PF07714
DomainSer-Thr/Tyr_kinase_cat_dom

MET BRAF ROR1

1.25e-03138293IPR001245
Domainzf-C4

NR1H3 ESRRG

2.31e-0346292PF00105
DomainNUCLEAR_REC_DBD_1

NR1H3 ESRRG

2.31e-0346292PS00031
DomainZnf_hrmn_rcpt

NR1H3 ESRRG

2.31e-0346292IPR001628
DomainNuclear_hrmn_rcpt

NR1H3 ESRRG

2.31e-0346292IPR001723
DomainZnF_C4

NR1H3 ESRRG

2.31e-0346292SM00399
DomainNUCLEAR_REC_DBD_2

NR1H3 ESRRG

2.31e-0346292PS51030
Domain-

NR1H3 ESRRG

2.41e-03472921.10.565.10
DomainHOLI

NR1H3 ESRRG

2.51e-0348292SM00430
DomainNucl_hrmn_rcpt_lig-bd

NR1H3 ESRRG

2.51e-0348292IPR000536
DomainHormone_recep

NR1H3 ESRRG

2.51e-0348292PF00104
Domain-

NR1H3 ESRRG

3.52e-03572923.30.50.10
DomainZnf_NHR/GATA

NR1H3 ESRRG

3.65e-0358292IPR013088
DomainTyrKc

MET ROR1

8.20e-0388292SM00219
Pubmed

Impact of MET expression on outcome in BRAF(V600E/K) advanced melanoma.

MET BRAF

8.73e-07233223802768
Pubmed

MET-Driven Resistance to Dual EGFR and BRAF Blockade May Be Overcome by Switching from EGFR to MET Inhibition in BRAF-Mutated Colorectal Cancer.

MET BRAF

8.73e-07233227325282
Pubmed

Reviving oncogenic addiction to MET bypassed by BRAF (G469A) mutation.

MET BRAF

8.73e-07233230224486
Pubmed

High-throughput oncogene mutation profiling shows demographic differences in BRAF mutation rates among melanoma patients.

MET BRAF

2.62e-06333225746038
Pubmed

Activated Hgf-Met Signaling Cooperates with Oncogenic BRAF to Drive Primary Cutaneous Melanomas and Angiotropic Lung Metastases in Mice.

MET BRAF

5.23e-06433231972251
Pubmed

The Interplay between HGF/c-met Axis and Nox4 in BRAF Mutated Melanoma.

MET BRAF

5.23e-06433233451139
Pubmed

Altiratinib Inhibits Tumor Growth, Invasion, Angiogenesis, and Microenvironment-Mediated Drug Resistance via Balanced Inhibition of MET, TIE2, and VEGFR2.

MET BRAF

8.72e-06533226285778
Pubmed

The impact of genomic changes on treatment of lung cancer.

MET BRAF

8.72e-06533223841470
Pubmed

New Targets in Non-Small Cell Lung Cancer.

MET BRAF

1.31e-05633227912827
Pubmed

LXR/ApoE Activation Restricts Innate Immune Suppression in Cancer.

NR1H3 LRP8

2.44e-05833229336888
Pubmed

BRAF activates PAX3 to control muscle precursor cell migration during forelimb muscle development.

MET BRAF

3.13e-05933227906130
Pubmed

Combinatorial CRISPR-Cas9 screens for de novo mapping of genetic interactions.

MET BRAF ROR1

4.26e-057133328319113
Pubmed

A dual-color FISH gene map of the proximal region of rat Chromosome 4 and comparative analysis in human and mouse.

MET BRAF

4.78e-051133211707776
Pubmed

The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.

MET TAF2 BRAF ROR1 LRP8

1.87e-0456933530639242
Pubmed

Functional proteomics mapping of a human signaling pathway.

SPRED1 ASXL2 HUWE1 KLF10 PIAS3

2.23e-0459133515231748
Pubmed

The splicing regulator Rbfox2 is required for both cerebellar development and mature motor function.

HUWE1 LRP8

4.53e-043333222357600
Pubmed

Gene Essentiality Profiling Reveals Gene Networks and Synthetic Lethal Interactions with Oncogenic Ras.

RCE1 BRAF

4.81e-043433228162770
Pubmed

E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.

RCE1 HUWE1 TEKT5 RYR1 ROR1

6.08e-0473633529676528
Pubmed

A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome.

SERTAD4 CDC25B ROR1 LRP8

6.50e-0442033428065597
Pubmed

Cooperative control of striated muscle mass and metabolism by MuRF1 and MuRF2.

CCAR1 PIAS3

7.00e-044133218157088
Pubmed

Quality Control of ER Membrane Proteins by the RNF185/Membralin Ubiquitin Ligase Complex.

HUWE1 RELT

7.34e-044233232738194
Pubmed

Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.

CCAR1 NR1H3 KLF10 PIAS3 ESRRG

9.25e-0480833520412781
GeneFamilyReceptor Tyrosine Kinases|CD molecules

MET ROR1

1.07e-0340222321
GeneFamilyArmadillo repeat containing|Protein phosphatase 1 regulatory subunits

CASP2 SPRED1 RYR1

1.32e-03181223694
GeneFamilyNuclear hormone receptors

NR1H3 ESRRG

1.61e-034922271
CoexpressionGSE32986_CURDLAN_LOWDOSE_VS_CURDLAN_HIGHDOSE_STIM_DC_DN

MET NR1H3 LYNX1 KLF10 LRP8

4.19e-06200325M8635
ToppCellTCGA-Uvea-Primary_Tumor-Uveal_Melanoma-Epithelioid_Cell-4|TCGA-Uvea / Sample_Type by Project: Shred V9

TAF2 RELT ROR1 LRP8

1.01e-051843349c56753e5e668be888662e4713cf4ce44e6c58fb
ToppCellfrontal_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_ALM_Slco2a1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

ANO4 MET TEKT5

1.29e-041333339d7a08170d38ae9b2ff10a0fa505aeb3aae2824d
ToppCellfrontal_cortex-Neuronal-glutamatergic_neuron-L5_PT|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

ANO4 TEKT5 RYR1

1.32e-04134333cb676d5bbc468bd3ce1b6712d41c986ee9221ac5
ToppCellPosterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6|Posterior_cortex / BrainAtlas - Mouse McCarroll V32

TEKT5 RYR1 ESRRG

1.63e-0414433308005be9e3367f78ef27e125d9cce5ca53f4bd2d
ToppCelldroplet-Kidney-KIDNEY-1m-Lymphocytic-lymphocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RELT CCDC180 RYR1

2.19e-041593333bab00f8fb7d9232538e50f83dd0fd70ddd16819
ToppCellClub_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id

MET GAN ESRRG

2.19e-04159333a7bcff268b1962a561fd2848e01ae16565bce895
ToppCelldroplet-Kidney-KIDNEY-1m-Lymphocytic-CD45|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RELT CCDC180 RYR1

2.23e-041603335bec867def73fa8531f8dad611679f4b44f573bd
ToppCell5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CASP2 LYNX1 FAAH2

2.27e-041613339cfbbcd38ec2e75376bbc26001964b6991ad0e21
ToppCell5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MET ADAT2 FAAH2

2.48e-0416633360060b03f2abfa3cc08107ab5a9f578e60e4ae16
ToppCell5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MET ADAT2 FAAH2

2.48e-04166333ec9161d388db5a257b8d125c14f9dd911d5d5d4a
ToppCell5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MET ADAT2 FAAH2

2.48e-041663334586d6725403f879fc96f67be579022587ce1906
ToppCellIonocyte-iono-1|World / Class top

TEKT5 ROR1 ESRRG

2.61e-041693334b68bcb4b5fc3cd2db23cd4edace7444aa2d605c
ToppCellIonocyte|World / Class top

TEKT5 ROR1 ESRRG

2.66e-04170333d2e592f2a679e6a8d32f2b752d9a3c493e50ced4
ToppCell343B-Fibroblasts-Fibroblast-B_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

SERTAD4 MET TAF2

2.75e-04172333bfb87a281a9cf6ad45b310bf8104fc0ab382b549
ToppCelldroplet-Lung-18m-Hematologic-myeloid-plasmacytoid_dendritic_cell-plasmacytoid_dendritic|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

LYNX1 RYR1 LRP8

2.75e-04172333422d311bba2dd5d8bece4e96ee8c86e78086b62d
ToppCelldroplet-Lung-18m-Hematologic-myeloid-plasmacytoid_dendritic_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

LYNX1 RYR1 LRP8

2.75e-041723331abb6fbb28c8aff384540493d0f70eeacaa751f4
ToppCell343B-Fibroblasts-Fibroblast-B_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

SERTAD4 MET TAF2

2.75e-04172333c6bc78fd63c9479a84ec0552b55c89750cad0fa5
ToppCellTCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-5|TCGA-Pancreas / Sample_Type by Project: Shred V9

RCE1 MET GAN

2.85e-0417433373e1ad4007d94fca25ed7c6fbe5d205d4e1b8a3b
ToppCelldroplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Hematologic-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RELT CDC25B RYR1

2.90e-041753333bca1aac2a2a1f46753b5f9462888f144ed8327b
ToppCellCOVID-19-kidney-Distal_Epi_Doublet_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type

MET ROR1 ESRRG

2.95e-0417633336f77d878a53b30465b0dea8333a3865dba75613
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ANO4 ROR1 LRP8

3.09e-04179333d1365d48d1b017a7917f4f63a82ac4720c3d87df
ToppCellCOVID-19-kidney-CD-IC-B|COVID-19 / Disease (COVID-19 only), tissue and cell type

ANO4 ESRRG FAAH2

3.25e-04182333ee6a8c356bbbdae55e4ea858337e079491f9f4aa
ToppCellControl-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ANO4 MET ROR1

3.30e-041833337eae9b3b4d1c9b135fa7cff348393d4adec474b4
ToppCellfacs-Limb_Muscle-ForelimbandHindlimb|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SPRED1 HUWE1 ROR1

3.41e-04185333eb7d3c1363d5fedc611f9c1a91ea823de251355e
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c3-EREG|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

SPRED1 NR1H3 LYNX1

3.41e-041853337bff05d8d34616adbaa0ea0b69eb30aa906bb9f8
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ANO4 ROR1 LRP8

3.57e-041883338de5a07301f9b5984680c873e5a92395b5ed3dd3
ToppCellSomatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ANO4 ROR1 LRP8

3.68e-041903333f22c118d552345f731d4d49f0bcb5765d93de3b
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ANO4 ROR1 LRP8

3.68e-04190333305fbef734c350cfbf786ca7ff6e07093aab56ea
ToppCellInfluenza_Severe-Non-classical_Monocyte|Influenza_Severe / Disease group and Cell class

SPRED1 NR1H3 LYNX1

3.74e-04191333197edf6feb1cfc71d88e532d74f77305a42a3486
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)

SPRED1 LYNX1 RELT

3.80e-041923337bcdbd97fa8c3bfccde426d44979601226913fc3
ToppCellClub_cells|World / lung cells shred on cell class, cell subclass, sample id

SERTAD4 MET LYNX1

3.86e-041933339d3165dc5763a07a7d873f497624d9d6528fa2db
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ANO4 ROR1 LRP8

3.86e-0419333353bcd50892c379b2a571751f6eb1062436339fe7
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ANO4 ROR1 LRP8

3.86e-041933334979862c0c16e6b4baa4c79894f1d237c861f5a5
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ANO4 ROR1 LRP8

3.86e-04193333c4b22b62f3cc7bf0ec0eba76e1504c236290bbc9
ToppCellSomatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ANO4 ROR1 LRP8

3.92e-04194333e5990880961d2469759ce4b3b20ae93ace3ebd1f
ToppCellPBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)

SPRED1 LYNX1 RELT

3.97e-04195333157f1f9b0521c9eba11806eb4b6802ff116ab912
ToppCellPBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Monocytic-Nonclassical_Monocyte|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)

SPRED1 LYNX1 RELT

3.97e-0419533395327f2818bcdca53dbd2971f674a9042a1392c6
ToppCell(001)_CD16+_Monocyte|World / immune cells in Peripheral Blood (logTPM normalization)

SPRED1 LYNX1 RELT

4.03e-0419633333843d550cbca03c044d593b1f6972e4d3871f7f
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Monocytic-Nonclassical_Monocyte|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)

SPRED1 LYNX1 RELT

4.03e-0419633329246378ffb1010fe6858da756ae3d13df2306ba
ToppCellCOVID-19_Severe-Non-classical_Monocyte|COVID-19_Severe / disease group, cell group and cell class

SPRED1 LYNX1 RELT

4.03e-04196333af9e8f5ef9d03862f707e105857309b55595b1b9
ToppCellremission-Non-classical_Monocyte|remission / disease stage, cell group and cell class

SPRED1 LYNX1 RELT

4.03e-04196333049d995986c20ce066bd64fcc2d2f1c2f8899883
ToppCellInfluenza_Severe-Non-classical_Monocyte|World / Disease group and Cell class

SPRED1 NR1H3 LYNX1

4.03e-041963338ef9810ee99082a9c803c7ecad6ceb5710d16b54
ToppCellHealthy/Control-Non-classical_Monocyte|World / Disease group and Cell class

SPRED1 LYNX1 RELT

4.09e-04197333470784932e1fc3ff69f27cd83f56d85b0c01af63
ToppCellmild_COVID-19-Non-classical_Monocyte|World / disease group, cell group and cell class (v2)

SPRED1 LYNX1 RELT

4.09e-04197333368644260f70895052a1d71171a9d882315354dd
ToppCellCOVID-19_Severe-Myeloid-Non-classical_Monocyte|COVID-19_Severe / Disease group, lineage and cell class

SPRED1 LYNX1 RELT

4.09e-04197333c5837b9a5a39a0f607a4e217ade9fc87d82a5406
ToppCellCOVID-19_Severe-Non-classical_Monocyte|World / disease group, cell group and cell class

SPRED1 LYNX1 RELT

4.09e-0419733360fee75b12451206bb2c07b61651a73c59ec6ade
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

MET ESRRG FAAH2

4.09e-041973337e93a97b5ac5ae2f77a4b3141082a1463fed00dd
ToppCellControl-Myeloid-Non-classical_Monocyte|Control / Disease group, lineage and cell class

SPRED1 LYNX1 RELT

4.16e-04198333ae0a51e63e2751a6d9dc0c8a3852680949173523
ToppCellPBMC-Severe-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

SPRED1 LYNX1 RELT

4.16e-041983339b8679b3dd8f4220d71f607b7080cb88d6e71129
ToppCellPBMC-Severe-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

SPRED1 LYNX1 RELT

4.16e-041983338b6b602ebe59b6dca6a22f17385d3160ff3ac67e
ToppCellPBMC-Control-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

SPRED1 LYNX1 RELT

4.16e-041983337d8fade2583c07a33dd83057cbce08e9fc77987a
ToppCellPBMC-Control-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

SPRED1 LYNX1 RELT

4.16e-041983339b47585653aaebd033c9b7bba93c7a7c35a4d60e
ToppCellHealthy_donor-Non-classical_Monocyte|World / disease group, cell group and cell class (v2)

SPRED1 LYNX1 RELT

4.16e-041983338a97c8b2a43e6d1e669ce18752841e2006744bd9
ToppCellPBMC-Severe-Myeloid-Non-classical_Monocyte|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

SPRED1 LYNX1 RELT

4.16e-041983335436c3ed16e10e00c686f1ab0b0a68728a1a9985
ToppCellmild_COVID-19-Non-classical_Monocyte|mild_COVID-19 / disease group, cell group and cell class (v2)

SPRED1 LYNX1 RELT

4.16e-04198333d7620b8d24e04ce1c563fc0ebe1625e03fe78950
ToppCellPBMC-Control-Myeloid-Non-classical_Monocyte|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

SPRED1 LYNX1 RELT

4.16e-041983333bc3dbd178043deadd7eef413b2761dc003abd6e
ToppCellremission-Non-classical_Monocyte|World / disease stage, cell group and cell class

SPRED1 LYNX1 RELT

4.16e-041983331c170655070acca00520b7cf9c510a04c0a90a8f
ToppCellPBMC-Severe-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

SPRED1 LYNX1 RELT

4.16e-041983334f67067d8142ca11b2d80195dac8d62a8d24d52c
ToppCellPBMC-Control-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

SPRED1 LYNX1 RELT

4.16e-041983338b5d30312bbcabc6911ff03e5028766d77203dff
ToppCellPBMC-Severe-Myeloid-Non-classical_Monocyte|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

SPRED1 LYNX1 RELT

4.16e-04198333b9030390316baf456135f85f831394e1e11ecf3e
ToppCellPBMC-Control-Myeloid-Non-classical_Monocyte|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

SPRED1 LYNX1 RELT

4.16e-04198333165d60b111a17d517a420c434733eefb98da240d
ToppCellPBMC-Severe-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

SPRED1 LYNX1 RELT

4.16e-04198333d36a3cda7e5f385d2391e9b0dfb027d3c4549320
ToppCellPBMC-Control-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

SPRED1 LYNX1 RELT

4.16e-04198333cbbdd44dfa95370c0fbaa65ba71d86bfee0ea379
ToppCellTCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma|TCGA-Colorectal / Sample_Type by Project: Shred V9

MET CDC25B LRP8

4.22e-0419933385b3b1ad01368dae4adbc9da7efc148e49992f69
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)

SPRED1 RELT KLF10

4.22e-0419933318b6087863fda22e3e2a2167e7daeb347df1d95b
ToppCellTCGA-Colorectal-Primary_Tumor|TCGA-Colorectal / Sample_Type by Project: Shred V9

MET CDC25B LRP8

4.22e-04199333c7d6a8398f2419b726a0461585d1ee0561654e3b
ToppCellPBMC-Convalescent-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

SPRED1 LYNX1 RELT

4.22e-0419933399eec995aa20ac22a8dd045382bd15a15db0b87a
ToppCellPBMC-Convalescent-Myeloid-Non-classical_Monocyte|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09)

SPRED1 LYNX1 RELT

4.22e-041993334eed28ef8c74d7131eeeabdd732a682d91e034dd
ToppCellPBMC-Convalescent-Myeloid-Non-classical_Monocyte|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

SPRED1 LYNX1 RELT

4.22e-04199333f234533254fd82b1ef2041e8405fe201d874018b
ToppCellPBMC-Convalescent-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

SPRED1 LYNX1 RELT

4.22e-041993333e09b3c2e2c57e5248981293020d2434e898e3e1
ToppCellBronchus_Control_(B.)-Epithelial-TX-Transitional_AT2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type

ANO4 ROR1 ESRRG

4.22e-04199333cd581d7330b471431ef427f8a4f5be553f70e068
ToppCellCOVID-19_Convalescent-Myeloid-Non-classical_Monocyte|COVID-19_Convalescent / Disease group, lineage and cell class

SPRED1 LYNX1 RELT

4.22e-041993335253948a1d7fc3da571860e14cdde4e18222e13b
ToppCellPBMC-Convalescent-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

SPRED1 LYNX1 RELT

4.22e-04199333ae6b4b4557c6a9223acdee2a79bc780c5916d38a
ToppCell5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

SERTAD4 LYNX1 RYR1

4.22e-041993336977f939ddbc47d4921f36c0a61a205259fe1284
ToppCell5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

SERTAD4 LYNX1 RYR1

4.22e-04199333fbd39d34636137d1b877dd8815d58f124990136b
ToppCellPBMC-Convalescent-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09)

SPRED1 LYNX1 RELT

4.22e-04199333aca9f75c690c6ed952bcbdc7e1e7eef7719f54ca
ToppCellCOVID-19-COVID-19_Convalescent-Myeloid-CD16+_Monocyte|COVID-19_Convalescent / Disease, condition lineage and cell class

SPRED1 LYNX1 RELT

4.28e-04200333f24abb2d54d6423ee886285e3c66a874ec59e1a3
ToppCellControl-Control-Myeloid-CD16+_Monocyte|Control / Disease, condition lineage and cell class

SPRED1 LYNX1 RELT

4.28e-042003338dd124a5aca897652ea68efbfc5a167b4cf31aef
ToppCellmild-Non-classical_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

SPRED1 LYNX1 RELT

4.28e-04200333334bab6bf93d455f3526e817ea5785d8b6ee531c
ToppCellNeuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2--L2-4|Neuronal / cells hierarchy compared to all cells using T-Statistic

ANO4 ROR1 LRP8

4.28e-04200333c65e6336725856c4b5f6aeba1cf86a23ec815d34
ToppCellInfluenza-Influenza_Severe-Myeloid-CD16+_Monocyte|Influenza_Severe / Disease, condition lineage and cell class

SPRED1 NR1H3 LYNX1

4.28e-042003331efdcfcd86e99fbe03db19a2a5ab10808eec282d
ToppCellCOVID-19-COVID-19_Severe-Myeloid-CD16+_Monocyte|COVID-19_Severe / Disease, condition lineage and cell class

SPRED1 LYNX1 RELT

4.28e-0420033358fbb7fc7159cbc417e6b457d60b7beba9b90da6
ToppCellCOVID-19-COVID-19_Mild-Myeloid-CD16+_Monocyte|COVID-19_Mild / Disease, condition lineage and cell class

SPRED1 LYNX1 RELT

4.28e-042003335c0eb14bdf1bfeaf93f6c3d521529bd5a4de50ce
ToppCellNeuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2-|Neuronal / cells hierarchy compared to all cells using T-Statistic

ANO4 ROR1 LRP8

4.28e-04200333117a25b3b9cdbc2e198381350a8362bee25e82e7
ToppCellNeuronal-Inhibitory-iB|Neuronal / cells hierarchy compared to all cells using T-Statistic

ANO4 ROR1 LRP8

4.28e-0420033345ddc5ef2caa87ada88327b63ba9b150a6bb3aa5
ToppCellNeuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2|Neuronal / cells hierarchy compared to all cells using T-Statistic

ANO4 ROR1 LRP8

4.28e-04200333d459e51507bf26865e6e7e04411379ec82a3edf8
DrugA-1155463

MET BRAF

6.11e-063332ctd:C000603579
DiseaseConventional (Clear Cell) Renal Cell Carcinoma

CASP2 MET RYR1 ROR1 FAAH2

3.82e-07148305C0279702
DiseasePapillary Renal Cell Carcinoma

CASP2 MET RYR1 FAAH2

8.48e-06128304C1306837
DiseaseRenal Cell Carcinoma

CASP2 MET RYR1 FAAH2

8.48e-06128304C0007134
DiseaseSarcomatoid Renal Cell Carcinoma

CASP2 MET RYR1 FAAH2

8.48e-06128304C1266043
DiseaseChromophobe Renal Cell Carcinoma

CASP2 MET RYR1 FAAH2

8.48e-06128304C1266042
DiseaseCollecting Duct Carcinoma of the Kidney

CASP2 MET RYR1 FAAH2

8.48e-06128304C1266044
DiseaseRASopathy

SPRED1 BRAF

1.04e-0415302cv:C5555857
DiseaseAdenocarcinoma of large intestine

MET BRAF ROR1

1.27e-0496303C1319315
DiseaseBenign neoplasm of stomach

MET BRAF

1.35e-0417302C0153943
DiseaseCarcinoma in situ of stomach

MET BRAF

1.35e-0417302C0154060
DiseaseNeoplasm of uncertain or unknown behavior of stomach

MET BRAF

1.35e-0417302C0496905
DiseaseStomach Carcinoma

MET BRAF

2.07e-0421302C0699791
DiseasePilocytic Astrocytoma

MET BRAF

2.95e-0425302C0334583
DiseaseCerebral Astrocytoma

MET BRAF

2.95e-0425302C0750935
DiseaseIntracranial Astrocytoma

MET BRAF

2.95e-0425302C0750936
DiseaseAstrocytoma

MET BRAF

2.95e-0425302C0004114
DiseaseJuvenile Pilocytic Astrocytoma

MET BRAF

2.95e-0425302C0280783
DiseaseDiffuse Astrocytoma

MET BRAF

2.95e-0425302C0280785
DiseaseGrade I Astrocytoma

MET BRAF

2.95e-0425302C1704230
DiseaseSubependymal Giant Cell Astrocytoma

MET BRAF

2.95e-0425302C0205768
DiseaseMixed oligoastrocytoma

MET BRAF

2.95e-0425302C0547065
DiseaseChildhood Cerebral Astrocytoma

MET BRAF

2.95e-0425302C0338070
DiseaseLymphatic Metastasis

MET BRAF

3.20e-0426302C0024232
DiseaseGemistocytic astrocytoma

MET BRAF

3.20e-0426302C0334581
DiseaseProtoplasmic astrocytoma

MET BRAF

3.20e-0426302C0334580
DiseaseFibrillary Astrocytoma

MET BRAF

3.20e-0426302C0334582
DiseaseAnaplastic astrocytoma

MET BRAF

3.45e-0427302C0334579
DiseaseMalignant neoplasm of kidney

MET BRAF

9.63e-0445302C0740457

Protein segments in the cluster

PeptideGeneStartEntry
MLACFPCFLRRKMPC

ERC2-IT1

1

O76042
MMRGLIPECCAVYRI

BRAF

186

P15056
PCIMCAAALRLMKIP

ADAT2

106

Q7Z6V5
LDCPSCDMMELRRRY

CCAR1

371

Q8IX12
MCPVCDKYCPFMRLS

ANO4

396

Q32M45
YRKEKRPVTRPDCMC

CCDC180

1396

Q9P1Z9
TPSKCYCRLKAMIMC

ASXL2

1396

Q76L83
CFPLHYPIRMSKRMC

OR2L3

126

Q8NG85
CNPLLYMVTMSPRVC

OR8B4

126

Q96RC9
PMDTYMRRKCQECRL

NR1H3

141

Q13133
ELVFRACMLPMLAPC

RCE1

176

Q9Y256
MYSKCQRLFRSPSMP

CDC25B

311

P30305
ECCRDLHMMKYPPSA

HUWE1

181

Q7Z6Z7
KLCMVRCLRPDRMTY

DNAH17

3826

Q9UFH2
CEYMLNSMPKRLCLV

ESRRG

116

P62508
RKPTAAMRCMCPLYD

GAN

286

Q9H2C0
AMRCMCPLYDPNRQL

GAN

291

Q9H2C0
MSDNPPRMEVCPYCK

C17orf80

1

Q9BSJ5
PMCRYAEDLAPMLKV

FAAH2

271

Q6GMR7
PMRCPAMVAYCMTTR

LYNX1

36

P0DP58
EKKFACPMCDRRFMR

KLF10

426

Q13118
YDPELYRMAMPCLCA

RYR1

2691

P21817
MRLPTRSDMICGYAC

CASP2

356

P42575
CPDTMWLGPDMKRCY

LRP8

721

Q14114
PMDRSAMCAFPIKYV

MET

356

P08581
PPAMKSLFTRMFCCK

TAF2

716

Q6P1X5
AMPYKRNPMRSERCC

ADSL

291

P30566
EKCMGMRKTFPCTPR

TEKT5

466

Q96M29
MAQDCPYRKRPRMAK

SERTAD4

166

Q9NUC0
LPCSEDCPPRMYSLM

ROR1

711

Q01973
MCPLGKMRLTVPCRA

PIAS3

326

Q9Y6X2
ERHEMVAKPPGMCCY

ZNF724

66

A8MTY0
SFIVPCMCCYVPLRM

SPRED1

411

Q7Z699
MKPSLLCRPLSCFLM

RELT

1

Q969Z4
YRCPLCMHSALDMTR

RCHY1

181

Q96PM5